UI Healthcare Mission Cancer and Blood - Pella — Pella, Iowa

UI Healthcare Mission Cancer and Blood - Pella is a clinical research site located in Pella, Iowa, United States 50219.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

UI Healthcare Mission Cancer and Blood - Pella has participated in 15 clinical trials with 15 currently active.

Therapeutic areas: Prostate Cancer (Adenocarcinoma), Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm.

Sponsors: Canadian Cancer Trials Group, Children's Oncology Group, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pella

Browse all research sites in Iowa · View every site in Pella

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UI Healthcare Mission Cancer and Blood - Pella?

UI Healthcare Mission Cancer and Blood - Pella has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UI Healthcare Mission Cancer and Blood - Pella conducted?

UI Healthcare Mission Cancer and Blood - Pella has 15 clinical trials on record, with 15 currently active. Their work covers Prostate Cancer (Adenocarcinoma), Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm.

Is UI Healthcare Mission Cancer and Blood - Pella accredited by Crixeo Clinical Trials?

UI Healthcare Mission Cancer and Blood - Pella has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UI Healthcare Mission Cancer and Blood - Pella?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.